BionTech

Coronavirus chronicle

Pfizer, BioNTech to supply 120 mln doses of coronavirus vaccine to Japan

The companies said, assuming success of the vaccine in clinical studies, they are on track to seek regulatory review for the vaccine as early as October

Coronavirus chronicle

US signs $2 billion vaccine deal with Pfizer and BioNTech

Coronavirus chronicle

Pfizer-BioNTech potential coronavirus vaccine shows promise in second early trial

Coronavirus chronicle

EU in talks with Moderna, BioNtech, CureVac to secure possible Covid vaccines - sources

Coronavirus chronicle

Pfizer, BioNTech's coronavirus vaccine candidates get FDA's 'fast track' status

Coronavirus chronicle

Pfizer, BioNTech's Covid-19 vaccine expected to be ready for approval by year end

Coronavirus chronicle

BioNTech and Pfizer's Covid-19 vaccine shows potential in human trial